RESCUE Act
U.S. Congress · HR8106 ·
Progression
Timing in context
Primary sponsor's contributions received (same period)
Adjacency in time is shown for context; it is not evidence of cause. Funded ≠ false — see the methodology.
What the bill says
Introduced 2026-03-26. Latest action: Referred to the Committee on Foreign Affairs, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
- Thomas H. Kean, Jr. (primary)
- Joe Wilson
Text versions
- Introduced in House — 2026-03-26 — XML
What analysts say
No nonpartisan analysis on file for this measure yet.
What politicians say
No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.
Action History
| Date | Action |
|---|---|
| 2026-03-26 | Introduced in House |
| 2026-03-26 | Referred to the Committee on Foreign Affairs, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Lobbying on this bill
Showing 3 of 3 bill mentions.
Honesty note: each filer below disclosed lobbying on this bill — that much the filing tells us. But the dollar figure is their total lobbying spend for the whole quarter across all their issues, not the amount spent on this bill, and the filing never says whether they supported or opposed it.
| Registrant (lobbying firm) | Client | Period | Reported quarterly amount | Extraction |
|---|---|---|---|---|
| FDD ACTION | FDD ACTION | Q2 2026 | $240,000 | |
| FDD ACTION | FDD ACTION | Q1 2026 | $270,000 | |
| JIM MASSIE & PARTNERS, LLC | COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS | Q1 2026 | $50,000 |
Source: Senate LDA filings.